KleenFoam, Antimicrobial Foam Soap with Aloe Vera, (Chloroxylenol 0.5%) 34 FL OZ (1000 mL) per ca...
FDA Drug Recall #D-0612-2025 — Class I — July 17, 2025
Recall Summary
| Recall Number | D-0612-2025 |
| Classification | Class I — Serious risk |
| Date Initiated | July 17, 2025 |
| Status | Ongoing |
| Voluntary | Voluntary: Firm initiated |
Recalling Firm
| Firm | DermaRite Industries, LLC |
| Location | North Bergen, NJ |
| Product Type | Drugs |
| Quantity | 6,973 cartridges |
Product Description
KleenFoam, Antimicrobial Foam Soap with Aloe Vera, (Chloroxylenol 0.5%) 34 FL OZ (1000 mL) per cartridge, DermaRite Industries LLC, 7777 West Side Avenue, North Bergen, NJ 07047. NDC 61924-093-34
Reason for Recall
Microbial Contamination of Non-Sterile Drug Product: The products were found to be contaminated with the bacteria Burkholderia cepecia.
Distribution Pattern
Nationwide within the USA
Lot / Code Information
Lot #: 30705A, Exp. Date 8/2025; 30771A, Exp. Date 9/2025; 30920A, Exp. Date 10/2025; 40016A, Exp. Date 1/2026; 40303A, Exp. Date 4/2026; 40428A, Exp. Date 5/2026; 40505A, Exp. Date 6/2026; 41053C, 41053A, 41053B, Exp. Date 12/2026, 50017A, Exp. Date 1/2027.
Other Recalls from DermaRite Industries, LLC
| Recall # | Classification | Product | Date |
|---|---|---|---|
| D-0170-2026 | Class II | Lantiseptic, Skin Protectant, Lanolin USP 30%, ... | Aug 27, 2025 |
| D-0168-2026 | Class II | KleenFoam Antimicrobial Foam Soap, Chloroxyleno... | Aug 27, 2025 |
| D-0162-2026 | Class II | DermaFungal, Antifungal Cream with 2% Miconazol... | Aug 27, 2025 |
| D-0165-2026 | Class II | DermaSarra, Camphor 0.5%, External Analgesic, 2... | Aug 27, 2025 |
| D-0161-2026 | Class II | DermaCerin, Skin Protectant Moisturizing Cream ... | Aug 27, 2025 |
Frequently Asked Questions
Injectable drugs and eye drops must be completely free of microbial contamination because they bypass the body's natural defenses. A contaminated injectable can introduce bacteria or fungi directly into the bloodstream, potentially causing sepsis, meningitis, or localized infections — all of which can be life-threatening. Contamination of sterile products almost always results in a Class I recall. If you received an injectable drug from a recalled lot, contact your healthcare provider immediately, even if you feel well, as some infections can have delayed onset.
Not necessarily. Many drug recalls are initiated because of quality system failures or test results that suggest a product might not meet specifications — even if no patients have reported harm. The FDA uses a precautionary approach: if there is reason to believe quality standards were not met, a recall is required regardless of whether adverse effects have been reported. Class I recalls typically involve a reasonable probability of harm; Class II recalls may cause temporary health issues; Class III recalls are for products unlikely to cause adverse health consequences but that still violate regulations.
Pharmacies typically receive recall notices directly from drug wholesalers and manufacturers within days of the recall being announced. Your pharmacist can look up whether any product in your prescription history matches a recalled lot number. For current recalls, the FDA publishes updates at FDA.gov/safety/recalls-market-withdrawals-safety-alerts and sends MedWatch email alerts for significant drug safety issues. You can sign up for MedWatch alerts at FDA.gov. Most major pharmacy chains also have their own recall notification systems that automatically alert pharmacists when a recalled product is in their inventory.
What Should You Do?
Stop using this medication if affected by this recall. Contact your pharmacist or prescribing doctor immediately for guidance. Do not flush medications — use a drug take-back program.